Topic - Eli Lilly And Company

Related Stories

A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. (AP Photo/Darron Cummings, File)

Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heights

By Tom Murphy - Associated Press

A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. The company said Wednesday, May 3, 2023, that its experimental Alzheimer’s drug appeared to slow worsening of the mind-robbing disease in a large study. (AP Photo/Darron Cummings, File)

Eli Lilly says experimental drug slows Alzheimer’s worsening

Associated Press

This combination of photos provided by Matthew Barlow shows him in November 2022, left, and April 2023 in California. Barlow, a 48-year-old health technology executive, said he has lost more than 100 pounds since November by using the drug Mounjaro and changing his diet. (Courtesy Matthew Barlow via AP)

Powerful new obesity drug poised to upend weight loss care

By Jonel Aleccia - Associated Press

FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly shares slipped Friday, Jan. 20, 2023, after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment. (AP Photo/Darron Cummings, File)

Lilly shares slip as FDA seeks more Alzheimer’s drug data

Associated Press

FILE- In this April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly’s new COVID-19 treatment helped the drugmaker’s fourth-quarter profit surge even though U.S. regulators approved its use late in the quarter. The antibody treatment bamlanivimab brought in $871 million in sales for Lilly after the Food and Drug Administration authorized emergency use in November 2020 for patients with mild-to-moderate COVID-19. . (AP Photo/Darron Cummings, File)

Lilly exec resigns after relationship that violated policy

By The Associated Press - Associated Press

FILE - In this Thursday Oct. 15, 2020 file photo, A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary. Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. The World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. (Zsolt Czegledi/MTI via AP, File)

FDA gives emergency approval for rheumatoid arthritis drug and remdesivir as COVID-19 treatment

By Shen Wu Tan - The Washington Times

This photo provided by Eli Lilly shows the drug Bamlanivimab. On Monday, Nov. 9, 2020, the Food and Drug Administration cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. (Courtesy of Eli Lilly via AP)

COVID-19 antibody treatment heading to states immediately: HHS

By Tom Howell Jr. - The Washington Times

Lilly misses profit projects as sales of diabetes drug slow

Associated Press

FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)

Lilly stays confident in possible COVID drug after setback

By TOM MURPHY - Associated Press

FILE - In this May 2020 photo provided by Eli Lilly, researchers prepare cells to produce possible COVID-19 antibodies for testing in a laboratory in Indianapolis. The drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study suggesting the drug reduced symptoms, the amount of virus and hospitalizations and ER visits for patients with mild or moderate COVID-19. Eli Lilly and Company announced the partial results Wednesday, Oct. 7 in a news release; they have not yet been published or reviewed by independent scientists. Its drug is similar to one that President Donald Trump received on Friday, Oct. 2 from Regeneron Pharmaceuticals Inc. (David Morrison/Eli Lilly via AP, File)

Lilly seeks emergency use of its antibody drug for COVID-19

By MARILYNN MARCHIONE - Associated Press

A Kashmiri health worker takes a nasal swab sample of a child to test for COVID-19 in Srinagar, Indian-controlled Kashmir, Tuesday, Oct. 6, 2020. India is the second worst-nation in terms of confirmed coronavirus caseload. (AP Photo/ Dar Yasin)

The Latest: Seoul region remains virus hot spot for S Korea

By The Associated Press - Associated Press

Partnership aims to preserve Indiana African American sites

Associated Press

FILE - This April 26, 2017, file photo shows the Eli Lilly &amp; Co. corporate headquarters in Indianapolis. Eli Lilly and Co. reports financial earns on Wednesday, Oct. 23, 2019. (AP Photo/Darron Cummings, File)

Lilly: 3Q Earnings Snapshot

Associated Press

Lilly: 2Q Earnings Snapshot

Associated Press

Lilly: 1Q Earnings Snapshot

Associated Press